While short-term benefits of IF, such as weight loss and improvements in lipid profiles, have been demonstrated, these effects appear primarily mediated by caloric restriction rather than unique attributes of intermittent fasting
Studies show weight loss surgery can also improve conditions caused by obesity, such as diabetes, sleep apnea, hypertension, and high cholesterol
Dit product is alleen voor onderzoeksdoeleinden
What Is Retatrutide Being Studied For
PlexusDx supports you through this phase with lifestyle guidance and, if needed, medication adjustments
In June 2024, Semaglutide was approved for weight management in China under the brand Novo Nordisk, launching in November and generating DKK 686 million in Q1 2025